Literature DB >> 3469139

Sexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men.

B A Evans, S G Dawson, K A McLean, S A Teece, P R Key, R A Bond, K D Macrae, W J Jesson, P P Mortimer.   

Abstract

A study of 304 sexually active homosexual men, most of whom had multiple casual partners, showed that receptive anogenital intercourse, independent of anal bleeding, was the only risk factor for HTLV-III/LAV transmission. There was no evidence that HTLV-III/LAV infection, measured by seropositivity, was transmitted by oroanal or orogenital routes, or that insertive penile intercourse constituted a risk. The strongest predictor of seropositivity proved to be homosexual activity for more than five years, which may lead to enhanced susceptibility to infection. Sexual exposure to European men seemed to be even more hazardous than sexual exposure to men from the United States of America, and emphasised the epidemiological importance of the promiscuous homosexual abroad. Skin complaints were the most common presenting symptoms in men with antibody to HTLV-III/LAV. Extrainguinal lymphadenopathy was the commonest sign, which was present in just under half of those who were seropositive. More than one quarter of seropositive patients had had sexual intercourse with a woman in the five years before being tested.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3469139      PMCID: PMC1012004          DOI: 10.1136/sti.62.6.384

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  9 in total

1.  Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome.

Authors:  M Melbye; R J Biggar; P Ebbesen; M G Sarngadharan; S H Weiss; R C Gallo; W A Blattner
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-08

2.  Chronic immune stimulation by sperm alloantigens. Support for the hypothesis that spermatozoa induce immune dysregulation in homosexual males.

Authors:  G M Mavligit; M Talpaz; F T Hsia; W Wong; B Lichtiger; P W Mansell; D M Mumford
Journal:  JAMA       Date:  1984-01-13       Impact factor: 56.272

3.  National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic results.

Authors:  H W Jaffe; K Choi; P A Thomas; H W Haverkos; D M Auerbach; M E Guinan; M F Rogers; T J Spira; W W Darrow; M A Kramer; S M Friedman; J M Monroe; A E Friedman-Kien; L J Laubenstein; M Marmor; B Safai; S K Dritz; S J Crispi; S L Fannin; J P Orkwis; A Kelter; W R Rushing; S B Thacker; J W Curran
Journal:  Ann Intern Med       Date:  1983-08       Impact factor: 25.391

4.  Prevalence of antibody to human T lymphotropic virus type III by risk group and area, United Kingdom 1978-84.

Authors:  P P Mortimer; W J Jesson; E M Vandervelde; M S Pereira
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-20

5.  Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.

Authors:  J K Nicholson; J S McDougal; H W Jaffe; T J Spira; M S Kennedy; B M Jones; W W Darrow; M Morgan; M Hubbard
Journal:  Ann Intern Med       Date:  1985-07       Impact factor: 25.391

6.  Early warning skin signs in AIDS and persistent generalized lymphadenopathy.

Authors:  M F Muhlemann; M G Anderson; F J Paradinas; P R Key; S G Dawson; B A Evans; I M Murray-Lyon; J J Cream
Journal:  Br J Dermatol       Date:  1986-04       Impact factor: 9.302

7.  Kaposi's sarcoma in homosexual men. A seroepidemiologic case-control study.

Authors:  M Marmor; A E Friedman-Kien; S Zolla-Pazner; R E Stahl; P Rubinstein; L Laubenstein; D C William; R J Klein; I Spigland
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

8.  Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.

Authors:  J J Goedert; M G Sarngadharan; R J Biggar; S H Weiss; D M Winn; R J Grossman; M H Greene; A J Bodner; D L Mann; D M Strong
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

9.  HTLV-III in the semen and blood of a healthy homosexual man.

Authors:  D D Ho; R T Schooley; T R Rota; J C Kaplan; T Flynn; S Z Salahuddin; M A Gonda; M S Hirsch
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

  9 in total
  14 in total

1.  Trends in sexual behaviour and HIV testing among women presenting at a genitourinary medicine clinic during the advent of AIDS.

Authors:  B A Evans; S M McCormack; R A Bond; K D MacRae
Journal:  Genitourin Med       Date:  1991-06

Review 2.  Human papillomavirus infection with particular reference to genital disease.

Authors:  C Sonnex
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

Review 3.  Human papillomaviruses and anal cancer.

Authors:  J D Oriel
Journal:  Genitourin Med       Date:  1989-08

4.  HIV transmitted by sexual intercourse but not by kissing.

Authors:  J W Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

5.  HIV transmitted by kissing.

Authors:  J W Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-18

6.  Trends in sexual behaviour and risk factors for HIV infection among homosexual men, 1984-7.

Authors:  B A Evans; K A McLean; S G Dawson; S A Teece; R A Bond; K D MacRae; R W Thorp
Journal:  BMJ       Date:  1989-01-28

Review 7.  Sexual transmission of HIV: routes, efficiency, cofactors and prevention. A survey of the literature.

Authors:  M van der Graaf; R Diepersloot
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

8.  Sexual behaviour in women attending a genitourinary medicine clinic.

Authors:  B A Evans; R A Bond; K D Macrae
Journal:  Genitourin Med       Date:  1988-02

9.  Survey of human immunodeficiency virus infection and sexually transmitted diseases in homosexual and bisexual men attending genitourinary medicine clinics in the UK during 1986-88. The British Cooperative Clinical Group.

Authors: 
Journal:  Genitourin Med       Date:  1990-10

10.  Risk profiles for genital infection in women.

Authors:  B A Evans; T Tasker; K D MacRae
Journal:  Genitourin Med       Date:  1993-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.